Does Argus HQ track new FDA actions for Atrium Medical Corporation automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Atrium Medical Corporation is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Atrium Medical Corporation?

3 total: 0 warning letters, 3 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Atrium Medical Corporation?

September 16, 2026. Argus HQ ingests new FDA enforcement records daily.

Has Atrium Medical Corporation had product recalls?

Yes, 3 recalls on file. See the full history below for each one.

FDA Enforcement History: Atrium Medical Corporation

At a glance: Argus HQ has recorded 3 FDA events for Atrium Medical Corporation: 0 warning letters, 3 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-09-16 to 2026-09-16. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

FDA action counts

Total FDA actions	3
Warning letters	0
Recalls	3
Approval records	0
Form 483 inspection citations	0
Most recent action	September 16, 2026

Enforcement history

On 2026-09-16, Argus HQ recorded an FDA recall for Atrium Medical Corporation, rated "high" severity in Argus HQ's classification: Atrium Medical Corporation — Class II recall: Getinge PVC Thoracic Catheter, Soft PVC Straight, 10 per Case; Size(Model Numbe…. On 2026-09-16, Argus HQ recorded an FDA recall for Atrium Medical Corporation, rated "high" severity in Argus HQ's classification: Atrium Medical Corporation — Class II recall: Getinge PVC Thoracic Catheter, Soft PVC Right Angle, 10 per Case; Size(Model Nu…. On 2026-09-16, Argus HQ recorded an FDA recall for Atrium Medical Corporation, rated "high" severity in Argus HQ's classification: Atrium Medical Corporation — Class II recall: Getinge PVC Thoracic Catheter, Firm PVC Straight, 10 per Case; Size(Model Numbe…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Atrium Medical Corporation has 3 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

Does Argus HQ track new FDA actions for Atrium Medical Corporation automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Atrium Medical Corporation is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Atrium Medical Corporation?: 3 total: 0 warning letters, 3 recalls, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Atrium Medical Corporation?: September 16, 2026. Argus HQ ingests new FDA enforcement records daily.
Has Atrium Medical Corporation had product recalls?: Yes, 3 recalls on file. See the full history below for each one.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Sep 16, 2026

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). FDA Enforcement History: Atrium Medical Corporation. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/atrium-medical-corporation

MLA

"FDA Enforcement History: Atrium Medical Corporation." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/atrium-medical-corporation.

Chicago

Argus HQ Research. "FDA Enforcement History: Atrium Medical Corporation." Digital Empire Holdings LLC. Accessed September 23, 2026. https://argushq.ai/company/atrium-medical-corporation.

BibTeX

@misc{argushq_argushq_ai_company_atrium_medical_corporation_2026,
  title = {FDA Enforcement History: Atrium Medical Corporation},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/company/atrium-medical-corporation},
  note = {Accessed: September 23, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗